Answers are grounded in this paper and cite their sources.
Objective This study aimed to analyse whether initiating nintedanib treatment at a reduced dose could improve the treatment continuation rate while maintaining efficacy in patients with connective tissue disease (CTD)-associated interstitial lung disease.
No takes yet. Share an insight, caveat, or question.
Ayano et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: